Skip to main content

Table 2 Prevalence of MDM2SNP309 subtypes

From: Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations

  BRCA1 BRCA2 BRCA1+2 Total
a: Prevalence of the MDM2 SNP309 subtypes in BRCA mutation carriers
Homozygotes G-G 29(26.1)% 16(23%)   45(25%)
Hetrozygotes 55(49.5%) 39(57.3%)   94(52.2%)
Homozygotes T-T 27(24.3%) 13(19.1%) 1(100%) 41(22.7%)
Total 111 68 1 180
b: Prevalence of the MDM2 SNP309 subtypes in the overall population
  BRCA Carriers Non Carriers
  Frequency Percent Frequency Percent
Homozygotes G-G 45 25.00% 68 25.00%
Hetrozygotes 94 52.20% 139 51.10%
Homozygotes T-T 41 22.80% 65 23.90%
Total 180   272